Survival Analysis Using a 5-Step Stratified Testing and Amalgamation Routine in Randomized Clinical Trials

04/28/2020
by   Devan V. Mehrotra, et al.
0

Randomized clinical trials are often designed to assess whether a test treatment prolongs survival relative to a control treatment. Increased patient heterogeneity, while desirable for generalizability of results, can weaken the ability of common statistical approaches to detect treatment differences, potentially hampering the regulatory approval of safe and efficacious therapies. A novel solution to this problem is proposed. A list of baseline covariates that have the potential to be prognostic for survival under either treatment is pre-specified in the analysis plan. At the analysis stage, using all observed survival times but blinded to patient-level treatment assignment, 'noise' covariates are removed with elastic net Cox regression. The shortened covariate list is used by a conditional inference tree algorithm to segment the heterogeneous trial population into subpopulations of prognostically homogeneous patients (risk strata). After patient-level treatment unblinding, a treatment comparison is done within each formed risk stratum and stratum-level results are combined for overall statistical inference. The impressive power-boosting performance of our proposed 5-step stratified testing and amalgamation routine (5-STAR), relative to that of the logrank test and other common approaches that do not leverage inherently structured patient heterogeneity, is illustrated using a hypothetical and two real datasets along with simulation results. Furthermore, the importance of reporting stratum-level comparative treatment effects (time ratios from accelerated failure time model fits in conjunction with model averaging and, as needed, hazard ratios from Cox proportional hazard model fits) is highlighted as a potential enabler of personalized medicine. A fiveSTAR R package is available at https://github.com/rmarceauwest/fiveSTAR.

READ FULL TEXT

page 1

page 2

page 3

page 4

research
06/02/2016

DeepSurv: Personalized Treatment Recommender System Using A Cox Proportional Hazards Deep Neural Network

Medical practitioners use survival models to explore and understand the ...
research
07/11/2018

Using Recursive Partitioning to Find and Estimate Heterogenous Treatment Effects In Randomized Clinical Trials

Heterogeneous treatment effects can be very important in the analysis of...
research
01/25/2019

A Sequential Significance Test for Treatment by Covariate Interactions

Due to patient heterogeneity in response to various aspects of any treat...
research
10/31/2022

Can the potential benefit of individualizing treatment be assessed using trial summary statistics alone?

Individualizing treatment assignment can improve outcomes for diseases w...
research
01/16/2019

Novel metrics for quantifying the capacity of subgroup-defining variables to yield efficient treatment rules

A major objective of subgroup analysis in clinical trials is to explore ...
research
02/26/2021

Penalized Poisson model for network meta-analysis of individual patient time-to-event data

Network meta-analysis (NMA) allows the combination of direct and indirec...
research
02/04/2020

Robust Optimal Design of Two-Armed Trials with Side Information

Significant evidence has become available that emphasizes the importance...

Please sign up or login with your details

Forgot password? Click here to reset